XML 32 R25.htm IDEA: XBRL DOCUMENT v3.26.1
Segment Reporting (Tables)
3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Schedule of Segment Information

The following table provides information about the Company's single operating segment which includes significant expenses by function along with significant non-cash expense items.

 

 

Three Months Ended
March 31,

 

 

2026

 

 

2025

 

Revenue:

 

 

 

 

 

Collaboration and license revenue

$

982

 

 

$

2,171

 

Operating expenses:

 

 

 

 

 

Research and development:

 

 

 

 

 

Personnel expenses

 

8,331

 

 

 

8,816

 

Facility-related and other

 

4,565

 

 

 

5,548

 

Laboratory supplies, research materials and studies

 

4,278

 

 

 

9,489

 

Clinical studies

 

2,890

 

 

 

3,695

 

Stock-based compensation

 

1,231

 

 

 

1,738

 

Depreciation expense

 

609

 

 

 

502

 

General and administrative:

 

 

 

 

 

Personnel expenses

 

3,517

 

 

 

3,019

 

Legal and professional fees

 

1,692

 

 

 

1,954

 

Facility-related and other

 

1,690

 

 

 

1,808

 

Stock-based compensation

 

1,234

 

 

 

1,676

 

Depreciation Expense

 

84

 

 

 

176

 

Other (expense) income:

 

 

 

 

 

Interest and other income, net

 

1,162

 

 

 

2,802

 

Interest expense

 

(689

)

 

 

(679

)

Net loss

$

(28,666

)

 

$

(34,127

)